Cheol Won Suh

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 140 citations

Medicine, Hematology, Oncology +15

High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies

Jun Kang, Jeonghyun Cho, Cheol Won Suh et al. · Annals of Hematology · 2010 · 79 citations

Medicine, Hematology, Oncology +10

Prognostic Factors and Clinical Outcomes of High-Dose Chemotherapy followed by Autologous Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma, Unspecified: Complete Remission at Transplantation and the Prognostic Index of Peripheral T Cell Lymphoma Are the Major Factors Predictive of Outcome

Deok‐Hwan Yang, Won Seog Kim, Seok Jin Kim et al. · Biology of Blood and Marrow Transplantation · 2009 · 54 citations · Full text

Medicine, Hematology, Oncology +14

Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study

Seong Jun Lee, Cheol Won Suh, Soon Il Lee et al. · The Korean Journal of Internal Medicine · 2014 · 34 citations · Full text

Medicine, Oncology, Pathology +8

Significantly Better Prognosis for Patients with Primary Plasma Cell Leukemia than for Patients with Secondary Plasma Cell Leukemia

Choong‐Hwan Cha, Chan Jeoung Park, Joo Ryung Huh et al. · Acta Haematologica · 2007 · 31 citations

Medicine, Hematology, Pathology +15